Intravenous Calcium Gluconate Injection Medication , 10ml /10 Calcium Gluconate Solution

Calcium Gluconate Injection 10ml /10% nonpyrogenic supersaturated solution of calcium gluconate for intravenous use only

Composition:

Each mL contains: Calcium gluconate 94 mg; calcium saccharate (tetrahydrate) 4.5 mg; water for injection q.s. Hydrochloric acid and/or sodium hydroxide may have been added for pH adjustment (6.0 to 8.2).

Calcium saccharate provides 6% of the total calcium and stabilizes the supersaturated solution of calcium gluconate.

Each 10 mL of the injection provides 93 mg elemental calcium (Ca++) equivalent to 1 g of calcium gluconate.

The structural formual is:

Clinical Pharmacology

Calcium is the fifth most abundant element in the body and is essential for maintenance of the functional integrity of nervous, muscular and skeletal systems, cell membranes and capillary permeability. It is also an important activator in many enzymatic reactions and is essential to a number of physiologic processes, including transmission of nerve impulses; contraction of cardiac; smooth and skeletal muscles; renal function; respiration; and blood coagulation. Calcium also plays regulatory roles in the release and storage of neurotransmitters and hormones; in the uptake and binding of amino acids; in cyanocobalamin (vitamin B12) absorption; and gastrin secretion.

Indications and Usage

Calcium Gluconate Injection, USP is used to treat conditions arising from calcium deficiencies such as hypocalcemic tetany, hypocalcemia related to hypoparathyroidism and hypocalcemia due to rapid growth or pregnancy. It is also used in the treatment of blackwidow spider bites to relieve muscle cramping and as an adjunct in the treatment of rickets, osteomalacia, lead colic and magnesium sulfate overdosage. Calcium gluconate has also been employed to decrease capillary permeability in allergic conditions, nonthrombocytopenic purpura and exudative dermatoses such as dermatitis herpetiformis and for prurifus of eruptions caused by certain drugs. In hyperkalemia, calcium gluconate may aid in antgonizing the cardiac toxicity, provided the patient is not receiving digitalis therapy.

Contraindications

Calcium slats are contraindicated in patients with ventricular fibrillation or hypercalcemia. Intravenous administration of calcium is contraindicated when serum calcium levels are above normal.

Warnings

For intravenous use only. Subcutaneous or intramuscular injection may cause severe necrosis and sloughing.

WARNING: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum.

Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.

Precautions

General

To avoid undesirable reactions that may follow rapid intravenous administration of calcium gluconate, the drug should be given slowly, e.g., approximately 1.5 mL over a period of one minute. When injected intravenously, calcium gluconate should be injected through a small needle into a large vein in order to avoid too rapid an increase in serum calcium and extravasation of calcium solution into the surrounding tissue with resultant necrosis.

Rapid injection of calcium gluconate may cause vasodilation, decreased blood pressure, bradycardia, cardiac arrhythmias, syncope and cardiac arrest.

Because of the danger involved in simultaneous use of calcium salts and drugs of the digitalis group, a digitalized patient should not receive an intravenous injection of a calcium compound unless indications are clearly defined.

Drug Interactions

The inotropic and toxic effects of cardiac glycosides and calcium are synergistic, and arrhythmias may occur if these drugs are given together (particularly when calcium is given intravenously). Intravenous administrationn of calcium should be avoided in patients receiving cardiac glycosides; if necessary, calcium should be given slowly in small amounts.

Calciumcomplexes tetracycline antibiotics rendering them inactive. The two drugs should not be given at the same time orally nor should they be mixed for parenteral administration.

Calcium Gluconate Injection has been reported to be incompatible with intravenous solutions containing various drugs. Published data are too varied and/or limited to permit generalizations, and specialized reference should be consulted for specific information.

Adverse Reactions

Patients may complain of tingling sensations, a sense of oppression or heat waves and a calcium or chalky taste following the intravenous administration of calcium gluconate.

Rapid intravenous injection of calcium salts may cause vasodilation, decreased blood pressure, bradycardia, cardiac arrhythmias, syncope and cardiac arrest. Use in digitalized patients may precipitate arrhythmias.

Local neocrosis and abscess formation may occur with intramuscular injection.

Dosage and Administration

The dose is dependent on the requirements of the individual patient. Intravenous Calcium Gluconate Injection must be administered slowly.

Adults - 500 mg to 2 g (5 to 20 mL)

Pediatric patients - 200 to 500 mg (2 to 5 mL)

Infants - Not more than 200 mg (not more than 2 mL)

Parenteral drug products should be inspected visually for particulate matter and discorloration prior to adminsitration, whenever solution and container permit.

Certificate of analysis

Established in 2014, WUHAN UNI-PHARMA BIO-TECH CO.,LTD is a professional manufacturer and exporter that is concerned with the design, development and production of pharmaceutical products ,Medical equipment, raw materials(API), veterinary drugs pharmaceutical Intermediate ,single-use medical devices, surgical dressing, dental material and instrument.

We are located in Wuhan city, Hubei province, with convenient transportation access. All of our products comply with international quality standards and are greatly appreciated in a variety of different markets throughout the world.

We have over 10 employees, boast an annual sales figure that exceeds USD10,000,000 and currently export 50% of our production worldwide. Our well-equipped facilities and excellent quality control throughout all stages of production enable us to guarantee total customer satisfaction.

As a result of our high quality products and outstanding customer service, we have gained a global sales network reaching Africa, southeast Asia, Middle east Countries ,South America countries and so on.

Committed to the mission of “Caring for Life and Attending to Health”, we strive to implement the strategy of internationalization and are engaged in services to the international pharmaceutical industry. We have rich international market experience and customer resources as well as excellent management and assurance system of international business.

If you are interested in any of our products or would like to discuss a custom order, please feel free to contact us. We are looking forward to forming successful business relationships with new clients around the world in the near future.